SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
416 Bob, <<the dosimetry requirements>> Interesting. Anyone else havbiowa-12/3/1999
415 <<Zevalin is given in a dosage independent of dosimetry in the PIII isn&#Bob L-12/2/1999
414 Bob L, <<How are they going to get clinical approval without dosimetry wbiowa-12/2/1999
413 There's a new article on Zevalin: Phase I/II Trial of IDEC-Y2B8 RadioimmunoBob L-12/2/1999
412 <i>A time honored function of marketing is to take problems and make themscaram(o)uche-11/30/1999
411 A time honored function of marketing is to take problems and make them into feRWReeves-11/29/1999
410 Peter, <i>Has CLTR disclosed whether there is in fact significant patienGordon James-11/29/1999
409 Gordon, Has CLTR disclosed whether there is in fact significant patient-to-patBiomaven-11/29/1999
408 RWR, <i>I think they are using a Holmium 166 Beta emitter which might beGordon James-11/29/1999
407 V1, Good points in your post, agreed on all. Nice to have some lively CLTR diGordon James-11/29/1999
406 PB- from a press release by Neorx in August Have not seen much on them-could tRWReeves-11/28/1999
405 Gordon, Great post. One other factor that should be considered is that NeupogeVector1-11/26/1999
404 JustObserving, Thanks very much for the Merrill info. A few thoughts: <i&Gordon James-11/26/1999
403 More on Zevalin Merrill just issued a report on Zevalin which has some relevaJust_Observing-11/25/1999
402 Bob, Great post. Thanks also to Gordon for another great one... Best regardsWTDEC-11/24/1999
401 Very nice board you folks have over here. Concerning the application and reviewdmkst1-11/23/1999
400 Thanks Bob, very timely. Here is a link to an article in the LA Times (via YahPseudo Biologist-11/23/1999
399 Thanks much for that update. The definition of grade 4 I was looking was a fewBob L-11/23/1999
398 Bob, <i>Thrombocytopenia has also been a problem with bexxar. For this Gordon James-11/22/1999
397 TITLE: Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody forBob L-11/22/1999
396 Thanks PB. Very instructive. Bob L-11/22/1999
395 PB, Thanks for a great post! Nice sites too! Best regards, WalterWTDEC-11/22/1999
394 Re <i> Yttrium finds its way to cortical bone (yes, were the marrow livesPseudo Biologist-11/22/1999
393 <<My hope and prayers are that we will get to 100% CRs>> DittoVector1-11/22/1999
392 Yeah, that's a deceased mount. Avalon are something else aren't they? Bob L-11/21/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News